Cardiac Dysfunction in the Mouse Model of Cancer Cachexia and Therapeutic Effects of Voluntary Exercise
-
- NONAKA Miki
- Department of Pain Control Research, The Jikei University School of Medicine
-
- KAKIGI Ryo
- Faculty of Management & Information Sciences, Josai International University
-
- KISHIDA Shosei
- Department of Biochemistry and Genetics, Kagoshima University Graduate School of Medical and Dental Sciences
-
- OHSHIMA Kaori
- Department of Pain Control Research, The Jikei University School of Medicine Pathology, Immunology and Microbiology, Graduate School of Medicine, The University of Tokyo
-
- GOTO Motohide
- Department of Occupational Toxicology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Japan
-
- UEZONO Yasuhito
- Department of Pain Control Research, The Jikei University School of Medicine
-
- UENO Susumu
- Department of Occupational Toxicology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Japan
Bibliographic Information
- Other Title
-
- がん悪液質モデルマウスに出現する心機能障害と自発運動負荷がもたらす治療的効果
Abstract
<p>【Aims】Recently, the interdisciplinary field of cardio-oncology has emerged to study the mechanism and prevention of cardiac dysfunction associated with cancer treatment. In this study, we investigated possible therapeutic effects of voluntary wheel running (VWR) on cardiac dysfunction observed in cancer-cachexia model mice established in our laboratory, since exercise therapy is known to be effective for patients with chronic heart failure.</p><p>【Methods】Mice were individually housed with free access to a wheel from 2 to 6 wks after implantation, to determine the effects of VWR on cancer cachexia-induced cardiac dysfunction.</p><p>【Results】VWR significantly suppressed the loss of heart and skeletal muscle weight as well as general symptoms of cachexia. Moreover, left ventricular ejection fraction significantly improved in cachexia group with VWR, compared to those without VWR. Microarray analysis revealed that the gene expression of “X”, which is an enzyme belonging to E3 ubiquitin ligase family but has not been reported to be related to heart failure, increased in the myocardium of cachexia mice, and that this increase was suppressed by VWR.</p><p>【Conclusions】These results suggest that the myocardial impairment associated with cancer cachexia may be caused by a different mechanism than that caused by heart failure, and that VWR may improve not only cachexia symptoms but also cachexia-induced cardiac dysfunction. In addition, the enzyme “X” may be one of key factors which are associated with myocardial atrophy and cardiac dysfunction on cancer cachexia. The pathway mediated by the enzyme “X” is currently being further analyzed.</p>
Journal
-
- Annual Meeting of the Japanese Society of Toxicology
-
Annual Meeting of the Japanese Society of Toxicology 49.1 (0), P-154-, 2022
The Japanese Society of Toxicology
- Tweet
Details 詳細情報について
-
- CRID
- 1390574666166611840
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
-
- Abstract License Flag
- Disallowed